ketanserin has been researched along with Peripheral Vascular Diseases in 3 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Ketanserin is a highly selective S2-serotonergic antagonist with additional alpha-adrenergic blocking activity, which has been proposed as a therapy for various cardiovascular diseases including hypertension." | 4.79 | Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease. ( Frishman, WH; Huberfeld, S; Kumar, A; Okin, S; Shareef, B; Wang, YH, 1995) |
| "Intermittent claudication has changed from being only a disabling symptom to being an indication for secondary prevention of coronary and cerebrovascular events." | 3.77 | [Role of antiaggregants in the treatment of arterial diseases of the lower limbs]. ( Boissel, JP, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frishman, WH | 1 |
| Huberfeld, S | 1 |
| Okin, S | 1 |
| Wang, YH | 1 |
| Kumar, A | 1 |
| Shareef, B | 1 |
| Hollenberg, NK | 1 |
| Boissel, JP | 1 |
3 reviews available for ketanserin and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Clinical Trials as Topic; Coronary Disease; | 1995 |
Implications of thrombosis and vasospasm in peripheral vascular disease.
Topics: Animals; Endothelium, Vascular; Humans; Ketanserin; Peripheral Vascular Diseases; Serotonin; Thrombo | 1991 |
[Role of antiaggregants in the treatment of arterial diseases of the lower limbs].
Topics: Humans; Intermittent Claudication; Ketanserin; Leg; Meta-Analysis as Topic; Peripheral Vascular Dise | 1991 |
1 trial available for ketanserin and Peripheral Vascular Diseases
| Article | Year |
|---|---|
[Role of antiaggregants in the treatment of arterial diseases of the lower limbs].
Topics: Humans; Intermittent Claudication; Ketanserin; Leg; Meta-Analysis as Topic; Peripheral Vascular Dise | 1991 |